Impact News +++ IDEANOMICS, INC.: 8-K Report (SEC Filing) +++ IDEANOMICS Aktie +3,45%

BRISTOL-MYERS Aktie

 >BRISTOL-MYERS Aktienkurs 
55.91 EUR    +0.3%    (Tradegate)
Ask: 56.20 EUR / 150 Stück
Bid: 56.03 EUR / 150 Stück
Tagesumsatz: 2944 Stück
Realtime Kurs von 8 bis 22 Uhr!
>BRISTOL-MYERS Performance
1 Woche: +1,0%
1 Monat: +3,3%
3 Monate: +8,0%
6 Monate: +10,5%
1 Jahr: +10,6%
laufendes Jahr: +10,8%
>BRISTOL-MYERS Aktie
Name:  BRISTOL-MYERS SQUIBBDL-10
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US1101221083 / 850501
Symbol/ Ticker:  BRM (Frankfurt) / BMY (NYSE)
Kürzel:  FRA:BRM, BRM.F, BRM:GR, NYSE:BMY
Index:  S&P500
Webseite:  https://www.bms.com/
Marktkapitalisierung:  125290 Mio. EUR
Umsatz:  35642.48 Mio. EUR
EBITDA:  15269.4 Mio. EUR
Gewinn je Aktie:  -1.898 EUR
Schulden:  39355.75 Mio. EUR
Liquide Mittel:  10940.02 Mio. EUR
Umsatz-/ Gewinnwachstum:  2.7% / -
KGV/ KGV lG:  - / 8.42
KUV/ KBV/ PEG:  2.93 / 3.31 / 1.09
Gewinnm./ Eigenkapitalr.:  -14.53% / -14.15%
Dividende je Aktie:  1.602 EUR
Dividendenrendite/ -schätzung:  2.9% / 2.94%
Div. Historie:  31.03.21 - 0.41819€
31.12.20 - 0.39846€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  BRISTOL-MYERS, BRISTOL MYERS
Letzte Datenerhebung:  16.06.21
>Eigentümer
Aktien: 2230 Mio. St.
f.h. Aktien: 2200 Mio. St.
Insider Eigner: 0.07%
Instit. Eigner: 74.95%
Leerverk. Aktien: 0.75%
 >Anleihen 
Es sind 14 Anleihen zur BRISTOL-MYERS Aktie bekannt.
>Peer Group

 
18.06.21 - 05:37
Bristol Myers Enters Into Collaboration For Eisai′s MORAb-202 Antibody Drug Conjugate (AFX)
 
NEW YORK CITY (dpa-AFX) - Bristol-Myers Squibb Co. (BMY) and Eisai Co., Ltd. have reached a strategic collaboration agreement for the co-development and co-commercialization of MORAb-202, an antib......
18.06.21 - 01:22
UPDATE 1-Bristol-Myers, Eisai in up to $3.1 bln deal to develop cancer drug candidate (Reuters EN)
 
...(Adds details on agreement, background) June 17 (Reuters) - Bristol......
18.06.21 - 00:58
Bristol-Myers and Eisai to jointly develop, market cancer drug (Reuters EN)
 
...(Reuters) - Bristol-Myers Squibb Co and Eisai Co on Thursday......
18.06.21 - 00:48
Bristol Myers Squibb (BMY) Dips More Than Broader Markets: What You Should Know (Zacks)
 
Bristol Myers Squibb (BMY) closed at $66.77 in the latest trading session, marking a -0.22% move from the prior day....
17.06.21 - 22:21
Bristol-Myers Squibb Company declares $0.49 dividend (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
17.06.21 - 22:19
Bristol Myers Squibb Announces Dividend (Business Wire EN)
 
NEW YORK--(BUSINESS WIRE)---- $BMY--Bristol Myers Squibb Announces Dividend...
15.06.21 - 22:22
OpenText Appoints Ann M. Powell to Board of Directors (PR Newswire)
 
WATERLOO, Ontario, June 15, 2021 /PRNewswire/ -- OpenText™ (NASDAQ: OTEX), (TSX: OTEX), today announced the appointment of Ann M. Powell to its board of directors. Ms. Powell is the current EVP, Global Chief Human Resource Officer for Bristol Myers...
15.06.21 - 18:48
Exelixis (EXEL) & Bristol Myers Team Up for Genitourinary Cancers (Zacks)
 
Exelixis (EXEL) collaborates with Bristol Myers to evaluate its next-generation tyrosine kinase inhibitor in combination with immuno-oncology therapies in advanced solid tumors....
14.06.21 - 17:57
Bristol-Myers Squibb Company (BMY) Investor Presentation - Slideshow (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
14.06.21 - 14:55
Exelixis, Bristol Myers To Evaluate XL092-Immuno-oncology Therapies In Advanced Solid Tumors (AFX)
 
NEW YORK CITY (dpa-AFX) - Exelixis Inc. (EXEL) said Monday that it has reached a clinical trial collaboration and supply agreement with Bristol-Myers Squibb Co. (BMY) for STELLAR-002, a new phase ......
14.06.21 - 14:36
Exelixis inks collaboration and supply agreement with Bristol Myers Squibb for cancer study (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
14.06.21 - 13:03
Bristol Myers Squibb Stock Remains Undervalued After Positive Data From Clinical Trials (Forbes)
 
The stock price of Bristol Myers Squibb (NYSE: BMY) has seen a 3% rise in yesterday's trading session (Jun 10), after the company announced positive data from phase three clinical trials of Breyanzi as a second line treatment in adults with relapsed...
13.06.21 - 15:06
How Big Is Bristol Myers Squibb′s Latest FDA Approval? (Fool)
 
It's an important win for a drug gained in the Celgene acquisition to reach blockbuster status....
12.06.21 - 00:48
Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know (Zacks)
 
Bristol Myers Squibb (BMY) closed the most recent trading day at $67.34, moving -0.07% from the previous trading session....
11.06.21 - 19:33
Bristol Myers (BMY) Announces Data on CAR T Cell Therapy Breyanzi (Zacks)
 
Bristol Myers (BMY) announces positive data on CAR T cell therapy, Breyanzi, in the second-line setting for patients with relapsed or refractory large B-cell lymphoma....
11.06.21 - 15:15
Bristol-Myers Squibb: Undervalued, With 13% Upside (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
11.06.21 - 13:03
Bristol Myers, Acceleron′s Reblozyl shows encouraging action in adults with beta thalassemia (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
11.06.21 - 12:07
BMY, Acceleron Announce New Data From Reblozyl Phase 2 Trial For Adults With NTD Beta Thalassemia (AFX)
 
NEW YORK CITY (dpa-AFX) - Bristol Myers Squibb (BMY) and Acceleron Pharma Inc. (XLRN) announced Friday the first data from the Phase 2 BEYOND study evaluating Reblozyl (luspatercept-aamt), a first......
11.06.21 - 07:00
Bristol-Myers Squibb - Don′t Miss Out On This (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
10.06.21 - 21:36
Bristol-Myers Squibb Company (BMY) Presents at Goldman Sachs 42nd Annual Global Healthcare Conference (Transcript) (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
>Zitat des Tages: Hungriges Pferd macht die Krippe sauber. - Sprichwort Frankreich
Partner:    >Tradegate Börse | >TraderFox Handelssignale | >Heibel-Ticker Börsenbrief | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf Twitter | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!